Open AccessAntiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
Author(s) -
Xinhui Wang,
Xiaoli Liu,
Peng Wang,
Yu Liu,
Fengna Yan,
Huiwen Yan,
Dongdong Zhou
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s330301
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , hazard ratio , proportional hazards model , viremia , liver cancer , hepatitis b virus , cirrhosis , hepatitis b , propensity score matching , antiviral therapy , hepatitis c , cancer , oncology , immunology , virus , chronic hepatitis , confidence interval
Although antiviral treatment has been shown to reduce mortality in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients with high HBV-DNA levels, it is still unclear whether it is useful in reducing mortality in patients with low HBV-DNA levels.